A detailed history of Oracle Alpha Inc. transactions in Viatris Inc stock. As of the latest transaction made, Oracle Alpha Inc. holds 15,425 shares of VTRS stock, worth $178,930. This represents 0.33% of its overall portfolio holdings.

Number of Shares
15,425
Previous 24,923 38.11%
Holding current value
$178,930
Previous $270 Million 31.77%
% of portfolio
0.33%
Previous 0.35%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$11.27 - $13.53 $107,042 - $128,507
-9,498 Reduced 38.11%
15,425 $184 Million
Q4 2023

Feb 14, 2024

BUY
$8.77 - $10.85 $218,574 - $270,414
24,923 New
24,923 $270 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $14.1B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Oracle Alpha Inc. Portfolio

Follow Oracle Alpha Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oracle Alpha Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oracle Alpha Inc. with notifications on news.